AtriCure ATRC Stock
AtriCure Price Chart
AtriCure ATRC Financial and Trading Overview
AtriCure stock price | 32.92 USD |
Previous Close | 49.08 USD |
Open | 49 USD |
Bid | 0 USD x 800 |
Ask | 0 USD x 1100 |
Day's Range | 48.72 - 49.69 USD |
52 Week Range | 32.51 - 52.96 USD |
Volume | 228.7K USD |
Avg. Volume | 292.51K USD |
Market Cap | 2.32B USD |
Beta (5Y Monthly) | 1.351408 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.95 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 59.8 USD |
ATRC Valuation Measures
Enterprise Value | 2.26B USD |
Trailing P/E | N/A |
Forward P/E | -54.577778 |
PEG Ratio (5 yr expected) | -2.35 |
Price/Sales (ttm) | 6.643463 |
Price/Book (mrq) | 5.101786 |
Enterprise Value/Revenue | 6.47 |
Enterprise Value/EBITDA | -100.373 |
Trading Information
AtriCure Stock Price History
Beta (5Y Monthly) | 1.351408 |
52-Week Change | 35.57% |
S&P500 52-Week Change | 20.43% |
52 Week High | 52.96 USD |
52 Week Low | 32.51 USD |
50-Day Moving Average | 45.73 USD |
200-Day Moving Average | 42.83 USD |
ATRC Share Statistics
Avg. Volume (3 month) | 292.51K USD |
Avg. Daily Volume (10-Days) | 235.35K USD |
Shares Outstanding | 47.24M |
Float | 45.88M |
Short Ratio | 5.63 |
% Held by Insiders | 2.71% |
% Held by Institutions | 99.55% |
Shares Short | 1.75M |
Short % of Float | 3.81% |
Short % of Shares Outstanding | 3.71% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -10.81% |
Operating Margin (ttm) | -9.81% |
Gross Margin | 74.42% |
EBITDA Margin | -6.44% |
Management Effectiveness
Return on Assets (ttm) | -3.67% |
Return on Equity (ttm) | -8.22% |
Income Statement
Revenue (ttm) | 349.3M USD |
Revenue Per Share (ttm) | 7.61 USD |
Quarterly Revenue Growth (yoy) | 25.39% |
Gross Profit (ttm) | 245.94M USD |
EBITDA | -22515000 USD |
Net Income Avi to Common (ttm) | -37759000 USD |
Diluted EPS (ttm) | -0.85 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 135.86M USD |
Total Cash Per Share (mrq) | 2.88 USD |
Total Debt (mrq) | 75.23M USD |
Total Debt/Equity (mrq) | 16.54 USD |
Current Ratio (mrq) | 3.815 |
Book Value Per Share (mrq) | 9.628 |
Cash Flow Statement
Operating Cash Flow (ttm) | -1588000 USD |
Levered Free Cash Flow (ttm) | -6261875 USD |
Profile of AtriCure
Country | United States |
State | OH |
City | Mason |
Address | 7555 Innovation Way |
ZIP | 45040 |
Phone | 513 755 4100 |
Website | https://www.atricure.com |
Industry | Medical Instruments & Supplies |
Sector(s) | Healthcare |
Full Time Employees | 1050 |
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and the Coolrail device, which enable users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Guided Coagulation System, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure compatible with a range of anatomical shapes. In addition, the company sells Lumitip Dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.
Q&A For AtriCure Stock
What is a current ATRC stock price?
AtriCure ATRC stock price today per share is 32.92 USD.
How to purchase AtriCure stock?
You can buy ATRC shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for AtriCure?
The stock symbol or ticker of AtriCure is ATRC.
Which industry does the AtriCure company belong to?
The AtriCure industry is Medical Instruments & Supplies.
How many shares does AtriCure have in circulation?
The max supply of AtriCure shares is 48.88M.
What is AtriCure Price to Earnings Ratio (PE Ratio)?
AtriCure PE Ratio is now.
What was AtriCure earnings per share over the trailing 12 months (TTM)?
AtriCure EPS is -0.95 USD over the trailing 12 months.
Which sector does the AtriCure company belong to?
The AtriCure sector is Healthcare.
AtriCure ATRC included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NASDAQ Composite IXIC | 16550.61 USD — |
-5.97
|
8.29B USD — | 16533.04 USD — | 16889.34 USD — | — - | 8.29B USD — |
Nasdaq US 700 Small Cap Index NQUS700SC | 2030.58 USD — |
-6.66
|
— — | 2030.36 USD — | 2092.28 USD — | — - | — — |
Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG | 2654.77 USD — |
-6.16
|
— — | 2649.3 USD — | 2734.22 USD — | — - | — — |
NASDAQ HealthCare IXHC | 920.53 USD — |
-2.33
|
— — | 917.85 USD — | 930.28 USD — | — - | — — |
NASDAQ Composite Total Return I XCMP | 20257.83 USD — |
-5.96
|
— — | 20236.33 USD — | 20672.41 USD — | — - | — — |
NASDAQ Global Market Composite NQGM | 1737.75 USD — |
-6
|
— — | 1724.84 USD — | 1770.8 USD — | — - | — — |
- {{ link.label }} {{link}}